Hypomethylating agents plus venetoclax <i>versus</i> intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-04-02
DOI
https://doi.org/10.3324/haematol.2025.300202
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia

Maël Heiblig, Kelly Ling, Eric S. Winer, Maximilian Stahl et al.
Haematologica
Acute Myeloid Leukemia Research
article

Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia

Maël Heiblig, Kelly Ling, Eric S. Winer, Maximilian Stahl, Nikolai Alexandrovich Podoltsev, Luis E. Aguirre, Marlise Rachael Luskin, Urbain Tauveron-Jalenques, Sylvain Garciaz, Guillaume Berton, Julia Gilhodes, Martha Wadleigh, Shai O. Shimony, Rebecca P. Bystrom, Andrius Žučenka, Aaron D. Goldberg, Amel Soua, Alexandre Iat, Leora Boussi, Lourdes Mendez, Jan Philipp Bewersdorf, Luca Lanino, Rory Michael Shallis, Eytan M. Stein, Evan C. Chen, Edouard Forcade, Thomas Cluzeau, Daniel J. DeAngelo, Richard M. Stone, Amer M. Zeidan, Jacqueline S. Garcia, Pierre-Yves Dumas, Raynier Devillier
article en

Abstract

No abstract available for this paper.
Haematologica
Memorial Sloan Kettering Cancer Center (US), Université de Bordeaux (FR), Inserm (FR), Vilnius University (LT), Aix-Marseille Université (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Centre Hospitalier Universitaire de Nice (FR), Moffitt Cancer Center (US), Yale University (US), Hospices Civils de Lyon (FR), Dana-Farber Cancer Institute (US), Duke Medical Center (US), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Centre de Recherche en Cancérologie de Marseille (FR), Institut Paoli-Calmettes (FR)
Bristol-Myers Squibb, Jazz Pharmaceuticals, Syndax Pharmaceuticals, Daiichi-Sankyo, Astellas Pharma, Servier, Swedish Orphan Biovitrum, Genentech
Openalex Percentile: Top 30%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.